Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
National Health Investors price target lowered to $61 from $64 at Truist » 08:53
09/26/22
09/26
08:53
09/26/22
08:53
NHI

National Health Investors

$59.16 /

-1.515 (-2.50%)

Truist analyst Michael…

Truist analyst Michael Lewis lowered the firm's price target on National Health Investors to $61 from $64 and keeps a Hold rating on the shares. The stock has performed well this year and the company's management believes there should be additional upside as National Health Investors ramps investments, the analyst tells investors in a research note. Lewis adds however that the current macro environment could put additional pressure on equities valuations, stating that his reduced price target is due to higher cost of capital and lower assumed earnings multiples.

ShowHide Related Items >><<
NHI National Health Investors
$59.16 /

-1.515 (-2.50%)

NHI National Health Investors
$59.16 /

-1.515 (-2.50%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
NHI National Health Investors
$59.16 /

-1.515 (-2.50%)

NHI National Health Investors
$59.16 /

-1.515 (-2.50%)

Over a week ago
Conference/Events
National Health Investors management to meet with Truist » 05:55
09/21/22
09/21
05:55
09/21/22
05:55
NHI

National Health Investors

$62.45 /

-0.35 (-0.56%)

Meeting to be held with…

Meeting to be held with CEO Mendelsohn and CFO Spaid in New York on September 21 hosted by Truist.

ShowHide Related Items >><<
NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

Conference/Events
National Health Investors management to meet with Truist » 04:55
09/21/22
09/21
04:55
09/21/22
04:55
NHI

National Health Investors

$62.45 /

-0.35 (-0.56%)

Meeting to be held in New…

Meeting to be held in New York on September 21 hosted by Truist.

ShowHide Related Items >><<
NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

NHI National Health Investors
$62.45 /

-0.35 (-0.56%)

Conference/Events
National Health Investors management to meet with Truist » 16:08
09/13/22
09/13
16:08
09/13/22
16:08
NHI

National Health Investors

$64.97 /

-1.91 (-2.86%)

Meeting to be held with…

Meeting to be held with CEO Mendelsohn and CFO Spaid in New York on September 21 hosted by Truist.

ShowHide Related Items >><<
NHI National Health Investors
$64.97 /

-1.91 (-2.86%)

NHI National Health Investors
$64.97 /

-1.91 (-2.86%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
NHI National Health Investors
$64.97 /

-1.91 (-2.86%)

NHI National Health Investors
$64.97 /

-1.91 (-2.86%)

Conference/Events
National Health Investors management to meet with Truist » 14:49
09/09/22
09/09
14:49
09/09/22
14:49
NHI

National Health Investors

$66.34 /

+0.87 (+1.33%)

Meeting to be held in New…

Meeting to be held in New York on September 21 hosted by Truist.

ShowHide Related Items >><<
NHI National Health Investors
$66.34 /

+0.87 (+1.33%)

NHI National Health Investors
$66.34 /

+0.87 (+1.33%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
NHI National Health Investors
$66.34 /

+0.87 (+1.33%)

NHI National Health Investors
$66.34 /

+0.87 (+1.33%)

Over a month ago
On The Fly
Skilled nursing facilities REITs seen boosted by final CMS reimbursement ruling » 10:42
08/01/22
08/01
10:42
08/01/22
10:42
CTRE

CareTrust REIT

$20.80 /

+0.16 (+0.78%)

, OHI

Omega Healthcare

$31.17 /

+0.14 (+0.45%)

, SBRA

Sabra Health Care

$15.47 /

+0.085 (+0.55%)

, LTC

LTC Properties

$42.61 /

+0.73 (+1.74%)

, NHI

National Health Investors

$64.63 /

-0.44 (-0.68%)

Shares of several skilled…

ShowHide Related Items >><<
SBRA Sabra Health Care
$15.47 /

+0.085 (+0.55%)

OHI Omega Healthcare
$31.17 /

+0.14 (+0.45%)

NHI National Health Investors
$64.63 /

-0.44 (-0.68%)

LTC LTC Properties
$42.61 /

+0.73 (+1.74%)

CTRE CareTrust REIT
$20.80 /

+0.16 (+0.78%)

CTRE CareTrust REIT
$20.80 /

+0.16 (+0.78%)

08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/03/22 Capital One
CareTrust REIT reinstated with an Equalweight at Capital One
04/18/22 Barclays
CareTrust REIT downgraded to Equal Weight from Overweight at Barclays
03/11/22 BMO Capital
CareTrust REIT downgraded to Market Perform from Outperform at BMO Capital
OHI Omega Healthcare
$31.17 /

+0.14 (+0.45%)

06/30/22 Jefferies
Omega Healthcare downgraded to Hold from Buy at Jefferies
06/14/22 Truist
Omega Healthcare price target lowered to $30 from $33 at Truist
06/03/22 Capital One
Omega Healthcare reinstated with an Equalweight at Capital One
SBRA Sabra Health Care
$15.47 /

+0.085 (+0.55%)

06/30/22 Jefferies
Sabra Health Care downgraded to Hold from Buy at Jefferies
06/03/22 Capital One
Sabra Health Care reinstated with an Equalweight at Capital One
LTC LTC Properties
$42.61 /

+0.73 (+1.74%)

08/01/22 Barclays
LTC Properties price target raised to $35 from $30 at Barclays
08/01/22 Berenberg
LTC Properties upgraded to Buy from Hold at Berenberg
06/21/22 BMO Capital
LTC Properties upgraded to Market Perform from Underperform at BMO Capital
NHI National Health Investors
$64.63 /

-0.44 (-0.68%)

06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
SBRA Sabra Health Care
$15.47 /

+0.085 (+0.55%)

OHI Omega Healthcare
$31.17 /

+0.14 (+0.45%)

NHI National Health Investors
$64.63 /

-0.44 (-0.68%)

LTC LTC Properties
$42.61 /

+0.73 (+1.74%)

CTRE CareTrust REIT
$20.80 /

+0.16 (+0.78%)

  • 13
    Oct
LTC LTC Properties
$42.61 /

+0.73 (+1.74%)

SBRA Sabra Health Care
$15.47 /

+0.085 (+0.55%)

OHI Omega Healthcare
$31.17 /

+0.14 (+0.45%)

LTC LTC Properties
$42.61 /

+0.73 (+1.74%)

CTRE CareTrust REIT
$20.80 /

+0.16 (+0.78%)

Recommendations
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling » 08:54
08/01/22
08/01
08:54
08/01/22
08:54
CTRE

CareTrust REIT

$20.64 /

+0.2 (+0.98%)

, OHI

Omega Healthcare

$31.00 /

+0.185 (+0.60%)

, SBRA

Sabra Health Care

$15.38 /

+0.07 (+0.46%)

, LTC

LTC Properties

$41.88 /

+1.1 (+2.70%)

, NHI

National Health Investors

$64.80 /

+0.85 (+1.33%)

Credit Suisse analyst…

Credit Suisse analyst Tayo Okusanya notes that on Friday, the Centers for Medicare & Medicaid Services issued the final ruling to update the Medicare payment policies and rates for skilled nursing facilities, or SNF, for fiscal year 2023, which is set to begin October 1, 2022. After initially proposing a 0.7% reduction in Medicare reimbursement back in April - the worst reimbursement rate in the last 10 years, the final ruling will result in a 2.7% increase in SNF Medicare payments, which is the best reimbursement rate in the last 10 years. Okusanya anticipates the SNF-exposed Healthcare REITs, including CareTrust REIT (CTRE), Omega Healthcare (OHI), Sabra Health Care (SBRA), LTC Properties (LTC), and National Health Investors (NHI), will react positively in response to the news during market hours on August 1, 2022.

ShowHide Related Items >><<
SBRA Sabra Health Care
$15.38 /

+0.07 (+0.46%)

OHI Omega Healthcare
$31.00 /

+0.185 (+0.60%)

NHI National Health Investors
$64.80 /

+0.85 (+1.33%)

LTC LTC Properties
$41.88 /

+1.1 (+2.70%)

CTRE CareTrust REIT
$20.64 /

+0.2 (+0.98%)

CTRE CareTrust REIT
$20.64 /

+0.2 (+0.98%)

06/03/22 Capital One
CareTrust REIT reinstated with an Equalweight at Capital One
04/18/22 Barclays
CareTrust REIT downgraded to Equal Weight from Overweight at Barclays
03/11/22 BMO Capital
CareTrust REIT downgraded to Market Perform from Outperform at BMO Capital
02/22/22 Barclays
CareTrust REIT price target lowered to $22 from $26 at Barclays
OHI Omega Healthcare
$31.00 /

+0.185 (+0.60%)

06/30/22 Jefferies
Omega Healthcare downgraded to Hold from Buy at Jefferies
06/14/22 Truist
Omega Healthcare price target lowered to $30 from $33 at Truist
06/03/22 Capital One
Omega Healthcare reinstated with an Equalweight at Capital One
04/26/22 Barclays
Omega Healthcare initiated with an Equal Weight at Barclays
SBRA Sabra Health Care
$15.38 /

+0.07 (+0.46%)

06/30/22 Jefferies
Sabra Health Care downgraded to Hold from Buy at Jefferies
06/03/22 Capital One
Sabra Health Care reinstated with an Equalweight at Capital One
05/25/22 Mizuho
Sabra Health Care upgraded to Buy from Neutral at Mizuho
LTC LTC Properties
$41.88 /

+1.1 (+2.70%)

08/01/22 Barclays
LTC Properties price target raised to $35 from $30 at Barclays
08/01/22 Berenberg
LTC Properties upgraded to Buy from Hold at Berenberg
06/21/22 BMO Capital
LTC Properties upgraded to Market Perform from Underperform at BMO Capital
06/03/22 Capital One
LTC Properties reinstated with an Equalweight at Capital One
NHI National Health Investors
$64.80 /

+0.85 (+1.33%)

06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
04/18/22 BMO Capital
National Health Investors price target lowered to $61 from $63 at BMO Capital
SBRA Sabra Health Care
$15.38 /

+0.07 (+0.46%)

OHI Omega Healthcare
$31.00 /

+0.185 (+0.60%)

NHI National Health Investors
$64.80 /

+0.85 (+1.33%)

LTC LTC Properties
$41.88 /

+1.1 (+2.70%)

CTRE CareTrust REIT
$20.64 /

+0.2 (+0.98%)

  • 13
    Oct
LTC LTC Properties
$41.88 /

+1.1 (+2.70%)

SBRA Sabra Health Care
$15.38 /

+0.07 (+0.46%)

OHI Omega Healthcare
$31.00 /

+0.185 (+0.60%)

LTC LTC Properties
$41.88 /

+1.1 (+2.70%)

CTRE CareTrust REIT
$20.64 /

+0.2 (+0.98%)

Over a quarter ago
Initiation
National Health Investors initiated with an Underperform at Credit Suisse » 16:30
06/22/22
06/22
16:30
06/22/22
16:30
NHI

National Health Investors

$59.47 /

+0.6 (+1.02%)

Credit Suisse analyst…

Credit Suisse analyst Tayo Okusanya initiated coverage of National Health Investors with an Underperform rating and $51 price target. The stock is set to give up recent gains as investors "realize that portfolio stabilization could be impeded by additional deferrals/abatements at smaller, troubled operators," argues Okusanya, who believes it is "a little early to call the bottom" in the stock.

ShowHide Related Items >><<
NHI National Health Investors
$59.47 /

+0.6 (+1.02%)

NHI National Health Investors
$59.47 /

+0.6 (+1.02%)

06/21/22 BMO Capital
National Health downgraded to Market Perform from Outperform at BMO Capital
06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
04/18/22 BMO Capital
National Health Investors price target lowered to $61 from $63 at BMO Capital
02/01/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
NHI National Health Investors
$59.47 /

+0.6 (+1.02%)

Downgrade
National Health downgraded to Market Perform from Outperform at BMO Capital » 05:06
06/21/22
06/21
05:06
06/21/22
05:06
NHI

National Health Investors

$60.76 /

+0.82 (+1.37%)

BMO Capital analyst John…

BMO Capital analyst John Kim downgraded National Health Investors to Market Perform from Outperform with an unchanged price target of $62. The shares have significantly outperformed peers as it has "commendably executed" on asset sales and operator transitions, Kim tells investors in a research note. Relative to peers, the analyst now sees limited share price upside and downgraded National Health on valuation.

ShowHide Related Items >><<
NHI National Health Investors
$60.76 /

+0.82 (+1.37%)

NHI National Health Investors
$60.76 /

+0.82 (+1.37%)

06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
04/18/22 BMO Capital
National Health Investors price target lowered to $61 from $63 at BMO Capital
02/01/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
01/07/22 BMO Capital
National Health upgraded to Outperform from Market Perform at BMO Capital
NHI National Health Investors
$60.76 /

+0.82 (+1.37%)

Earnings
National Health Investors backs FY22 normalized FFO view $4.38-$4.48  17:32
06/06/22
06/06
17:32
06/06/22
17:32
NHI

National Health Investors

$59.25 /

+ (+0.00%)

Consensus $4.50.

ShowHide Related Items >><<
NHI National Health Investors
$59.25 /

+ (+0.00%)

NHI National Health Investors
$59.25 /

+ (+0.00%)

06/03/22 Capital One
National Health Investors reinstated with an Overweight at Capital One
04/18/22 BMO Capital
National Health Investors price target lowered to $61 from $63 at BMO Capital
02/01/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
01/07/22 BMO Capital
National Health upgraded to Outperform from Market Perform at BMO Capital
NHI National Health Investors
$59.25 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.